Navigation Links
NeurogesX Receives Qutenza®-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
Date:11/19/2010

prescription strength capsaicin, is approved by the U.S. Food and Drug Administration (FDA) for the management of neuropathic pain associated with postherpetic neuralgia (PHN).

Clinical studies have shown that a single one-hour Qutenza application can provide three months relief from pain associated with PHN, the nerve pain that can occur after shingles.

In clinical trials, serious adverse reactions included application-associated pain and increase in blood pressure. The most common treatment-emergent adverse reactions (greater than or equal to 5% of Qutenza patients and greater than control) were application-site erythema, application-site pain, application-site pruritus, and application-site papules.

Qutenza is also approved in the E.U. and is marketed by Astellas Pharma Europe Ltd. (Astellas), the European subsidiary of Tokyo-based Astellas Pharma Inc.

About NeurogesX, Inc.NeurogesX, Inc. (Nasdaq: NGSX) is a San Francisco Bay Area-based biopharmaceutical company focused on developing and commercializing novel pain management therapies. NeurogesX was founded on the concept that use of prescription-strength capsaicin could help manage the pain associated with neuropathic pain conditions. Since its inception, NeurogesX has leveraged its passion to help people with pain to efficiently develop this concept, resulting in the commercial launch of Qutenza® (capsaicin) 8% patch in 2010. The Company continues to apply its knowledge and expertise in the development of other novel treatments for pain.

The Company's lead product, Qutenza, is a localized dermal delivery system containing prescription strength capsaicin that is currently approved in the United States and the European Union. Qutenza is now available in the United States for the management of neuropathic pain associated with postherpetic neuralgia (PHN). In Europe, Qutenza is
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
2. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
3. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
4. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
5. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
6. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
7. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
8. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
9. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
10. NeurogesX to Present at JMP Securities Healthcare Focus Conference
11. NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015 Patterson Medical, formerly the ... PDCO ), is now an independent company with ... Patterson Medical by Madison Dearborn Partners (MDP).  ... for a transition period before rebranding as the ... medicine products.  With the focused resources and expertise ...
(Date:8/28/2015)... The scientific team of a new biotech company ... academics in the field of aging Prof. Robert J. ... for model animals - 10 fold for nematodes) has recently ... primarily, around the stability and stress resistance of certain gene ... analysis of a model gene network links aging, stress resistance, ...
(Date:8/28/2015)... PITTSBURGH , Aug. 28, 2015 /PRNewswire/ ... that its shareholders have approved Mylan,s proposed acquisition ... TASE) and the related issuance of Mylan ordinary ... meeting of shareholders held today. The transaction received ... extraordinary general meeting. In addition, the transaction received ...
Breaking Medicine Technology:Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9
... July 27 For the first time ever, large numbers of ... Pharma ChemOutsourcing at the Jersey Shore this fall. Most are chemists by ... (API,s). , , , ... has found a home on the East Coast where the majority of ...
... July 27 Thoratec Corporation (Nasdaq: ... support therapies to save, support and restore failing hearts, ... previously announced agreement to sell its International Technidyne Corporation ... came about as the result of the failure of ...
Cached Medicine Technology:Big Pharma Chemists Turning Out in Large Numbers for ChemOutsourcing Extravaganza Event on September 14-16, 2010 at Jersey Shore Beach Resort 2Thoratec Announces Termination of Proposed Sale of ITC 2Thoratec Announces Termination of Proposed Sale of ITC 3
(Date:8/28/2015)... ... August 28, 2015 , ... Dr. Gregory K. Toumayan, D.C., Q.M.E., is ... in shoulder pain, hip pain, neck pain, stiffness, muscle spasms, and numbness. ... University of Illinois, and then went on to earn his title of Doctor of ...
(Date:8/28/2015)... ... , ... Mendon, IL, home of the Adams County Fairgrounds, was treated once ... good cause. In its second year, the “Music With A Mission” benefit concert was ... “Mission” of “Music With A Mission” is to raise money to help fund music ...
(Date:8/28/2015)... , ... August 28, 2015 , ... The newest therapy ... be available for general use any time soon, according to educational website Surviving Mesothelioma. ... therapy that received orphan drug designation for mesothelioma last week from the FDA, will ...
(Date:8/28/2015)... ... August 28, 2015 , ... External Counterpulsation, also known as ECP or EECP, ... External Counterpulsation (EECP or ECP) machines with a full clinic licence to help people ... since 2007 helping people prevent and reverse heart disease through its evidence-based ...
(Date:8/28/2015)... ... August 28, 2015 , ... Inc. magazine today ranked ... exclusive ranking of the nation’s fastest-growing private companies. The list was unveiled online at ... of 85% over the last three years, PREVENT ranks higher on the list than ...
Breaking Medicine News(10 mins):Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2Health News:Buy New External Counterpulsation (EECP or ECP) With Heart Fit Clinic 2Health News:PREVENT Life Safety Ranks No. 3660 on the 2015 Inc. 5000 With Three-Year Sales Growth of 85% 2
... at the University of Pennsylvania School of Medicine have ... gained insight into cardiovascular development, all thanks to a ... of Medicine, graduate student Benjamin Kleaveland, and colleagues report ... that a human vascular condition called Cerebral Cavernous Malformation ...
... Disease prevention and health promotion programs ... but the Congressional Budget Office has largely overlooked ... according to a white paper released today by ... of the nation,s leading authorities on public health ...
... Californians,with Alzheimer,s disease will nearly double to 1.1 million ... as every region of the state, experiencing,dramatic increases, according ... the Alzheimer,s Association. , California ... in eight lifetime risk,of developing Alzheimer,s disease, a progressive, ...
... Pa., Feb. 25 Visitors to the Lancaster County ... of their health using a bilingual, touch-activated Women,s Wellness ... Commission for Women in partnership with the Department of ... else but themselves, and their own health ends up ...
... have suffered such problems, study finds , , WEDNESDAY, Feb. 25 ... rotator cuff problems, according to new research that finds the ... on an analysis of health data on more than two ... even distant relations, such as third cousins, can predict an ...
... Feb. 25 In a unified effort to ... in Michigan, MidMichigan Health will go trans fat ... fats will be eliminated from patient meals, cafeteria ... shelves at MidMichigan Medical Centers in Alma, Clare, ...
Cached Medicine News:Health News: Big-hearted fish reveals genetics of cardiovascular condition 2Health News: Big-hearted fish reveals genetics of cardiovascular condition 3Health News:CBO's Take on Prevention Programs 'Misses the Point' of Health Reform 2Health News:CBO's Take on Prevention Programs 'Misses the Point' of Health Reform 3Health News:Alzheimer's Association Releases Report That Predicts Doubling in Number of Californians With Neurological Disorder 2Health News:Alzheimer's Association Releases Report That Predicts Doubling in Number of Californians With Neurological Disorder 3Health News:Alzheimer's Association Releases Report That Predicts Doubling in Number of Californians With Neurological Disorder 4Health News:Pennsylvania Commission for Women Helps Lancaster Women Access Health Information 2Health News:Genes May Help Drive Rotator Cuff Injury 2Health News:Genes May Help Drive Rotator Cuff Injury 3Health News:MidMichigan Health Cuts Out Trans Fats Beginning March 1 2
1000 L, Racked, Pre-sterilized, 100 tips/rack Recommended for 500 and 1000 L pipettes....
Inquire...
300 L, Racked, Filtered, Pre-sterilized, 96 tips/rack Recommended for 250 and 300 L pipettes....
... false signals and contamination caused by ... Barrier Tips offer performance and economy ... (PCR(a)), radioactive isotopes, tissue culture fluids, ... , ,Promega Barrier Tips are made ...
Medicine Products: